Help Therapeutics iPSC-RPE program approved for provincial and municipal projects

Recently, according to the announcement of Jiangsu Provincial Science and Technology Department and Nanjing Science and Technology Bureau, the clinical translational research and preclinical efficacy research project of "Induced Pluripotent Stem Cell-derived Retinal Pigment Epithelial Cells (iPSC-RPE) for Age-Related Macular Degeneration (AMD)" conducted by Help Therapeutics Technology Co.

List of projects to be established by the provincial science and technology program special funds (key R&D program social development) in 2022
The list of proposed projects for life and health science and technology special projects in 2022 (in no particular order)

Professor Liu Qinghuai of Jiangsu Provincial People's Hospital said, "The early development of transplanted cells that can solve ethical issues and have both safety and efficacy of treatment has important clinical value and is a key part of advancing the clinical translation of cell transplantation in China. Help Therapeutics has rich clinical and translational experience in the field of iPSC, and combined with the clinical advantages of the People's Hospital of Jiangsu Province in ophthalmology, this project is expected to fill the weak link in this field in China and has broad prospects for industrialization."

Professor Yuan Songtao of Jiangsu Provincial People's Hospital said, "The unique high-scale industrial-grade cell wisdom platform of Help Therapeutics ensures the safety and homogeneity of transplanted cells production, and the ophthalmology of Jiangsu Provincial People's Hospital also has a perfect ophthalmic basic and clinical research foundation. This in-depth cooperation between the two parties will jointly promote the transformation of cell therapy to clinical application, which has a very important strategic value and considerable social benefits in helping to solve the field of aging diseases."

The cooperation with Jiangsu Provincial People's Hospital is another innovative move of Help Therapeutics after the "University of Macau Joint Laboratory". Help Therapeutics actively responds to the national "strategy of strengthening the country with scientific and technological talents", adheres to the guiding principle of "scientific and technological innovation, cooperation and sharing", and actively establishes cooperation and innovation ecology with scientific research institutions and clinical institutions in China, with the mission of "letting human beings With the mission of "Let people live to 120 years old healthily" and "Cure difficult to treat degenerative diseases" as the grip, we build the "Help Thera-X" innovation platform inside and outside, and explore the road with one heart to win and live together.

We welcome more scientists to join Help Therapeutics innovation cooperation ecology, so that we can join hands with each other and embark on a new journey to "renew the destiny of the human community".